N
REPL icon

Nuveen’s Replimune Group REPL Stock Holding History

Nuveen’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$441K Hold
57,614
– – ﹤0.01% 2891
2025
Q4 		$560K Hold
57,614
– – ﹤0.01% 2831
2025
Q3 		$241K Sell
57,614
-69,713
-55% -$445K ﹤0.01% 3110
2025
Q2 		$1.18M Sell
127,327
-544,084
-81% -$4.75M ﹤0.01% 2524
2025
Q1 		$6.55M Buy
671,411
+3,777
+0.6% +$46.7K ﹤0.01% 1782
2024
Q4 		$8.09M Buy
667,634
+347,993
+109% +$4.23M ﹤0.01% 1709
2024
Q3 		$3.5M Buy
319,641
+87,674
+38% +$891K ﹤0.01% 2154
2024
Q2 		$2.09M Buy
231,967
+114,980
+98% +$801K ﹤0.01% 2374
2024
Q1 		$956K Hold
116,987
– – ﹤0.01% 2725
2023
Q4 		$986K Buy
116,987
+12,756
+12% +$148K ﹤0.01% 2738
2023
Q3 		$1.78M Sell
104,231
-89,833
-46% -$1.76M ﹤0.01% 2344
2023
Q2 		$4.51M Buy
194,064
+3,770
+2% +$73.7K ﹤0.01% 1972
2023
Q1 		$3.36M Sell
190,294
-7,428
-4% -$177K ﹤0.01% 2111
2022
Q4 		$5.38M Buy
197,722
+61,447
+45% +$1.28M ﹤0.01% 1865
2022
Q3 		$2.35M Sell
136,275
-7,689
-5% -$147K ﹤0.01% 2318
2022
Q2 		$2.52M Buy
143,964
+32,445
+29% +$533K ﹤0.01% 2320
2022
Q1 		$1.76M Buy
111,519
+25,569
+30% +$482K ﹤0.01% 2559
2021
Q4 		$2.26M Sell
85,950
-7,044
-8% -$211K ﹤0.01% 2515
2021
Q3 		$3.03M Sell
92,994
-15,488
-14% -$503K ﹤0.01% 2477
2021
Q2 		$4.17M Buy
108,482
+182
+0.2% +$6.22K ﹤0.01% 2336
2021
Q1 		$3.3M Sell
108,300
-16,121
-13% -$604K ﹤0.01% 2372
2020
Q4 		$4.75M Sell
124,421
-128,529
-51% -$5.36M ﹤0.01% 2106
2020
Q3 		$5.82M Buy
252,950
+46,558
+23% +$1.06M ﹤0.01% 1842
2020
Q2 		$5.13M Buy
206,392
+40,871
+25% +$723K ﹤0.01% 1885
2020
Q1 		$1.65M Buy
165,521
+120,425
+267% +$1.8M ﹤0.01% 2279
2019
Q4 		$647K Buy
45,096
+15,304
+51% +$221K ﹤0.01% 2843
2019
Q3 		$414K Buy
29,792
+2,108
+8% +$25.9K ﹤0.01% 2997
2019
Q2 		$406K Buy
+27,684
New +$400K ﹤0.01% 3066

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's REPL Position: Q1 2026 in Review

Nuveen held its Replimune Group (REPL) position steady in Q1 2026 at 57,614 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

Nuveen first reported a position in REPL in Q2 2019 and has held it in 28 quarters since. The position peaked at $8.09M in Q4 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Nuveen held 57,614 shares of Replimune Group worth $441K as of Q1 2026.
  • Nuveen left its Replimune Group share count unchanged in Q1 2026.
  • Replimune Group made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2891 holding.
  • Nuveen first reported a position in Replimune Group in Q2 2019 and has held it in 28 quarters since.
  • Nuveen's Replimune Group position peaked at $8.09M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.